Comparative antimicrobial activities of the penem WY-49605 (SUN5555) against recent clinical isolates from five U.S. medical centers.

Eitemau Tebyg

• In vitro susceptibilities of 185 penicillin-susceptible and -resistant pneumococci to WY-49605 (SUN/SY 5555), a new oral penem, compared with those to penicillin G, amoxicillin, amoxicillin-clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime, and cefdinir.
  gan: Spangler, S K, et al.
  Cyhoeddwyd: (1994)
• Antibacterial activity of WY-49605 compared with those of six other oral agents and selection of disk content for disk diffusion susceptibility testing.
  gan: Fuchs, P C, et al.
  Cyhoeddwyd: (1995)
• In vitro antibacterial activity and beta-lactamase stability of SY5555, a new oral penem antibiotic.
  gan: Inoue, E, et al.
  Cyhoeddwyd: (1994)
• In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. Medical Centers in 1992 and 1993.
  gan: Barry, A L, et al.
  Cyhoeddwyd: (1994)
• Activity of WY-49605 compared with those of amoxicillin, amoxicillin-clavulanate, imipenem, ciprofloxacin, cefaclor, cefpodoxime, cefuroxime, clindamycin, and metronidazole against 384 anaerobic bacteria.
  gan: Spangler, S K, et al.
  Cyhoeddwyd: (1994)